1-hydroxy-3-amino-2-pyrrolidone has been researched along with Trigeminal Neuralgia in 2 studies
1-hydroxy-3-amino-2-pyrrolidone: a CNS depressant; structure in first source
Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kayser, V | 2 |
| Latrémolière, A | 1 |
| Hamon, M | 1 |
| Bourgoin, S | 1 |
| Christensen, D | 1 |
| Gautron, M | 1 |
| Guilbaud, G | 1 |
2 other studies available for 1-hydroxy-3-amino-2-pyrrolidone and Trigeminal Neuralgia
| Article | Year |
|---|---|
N-methyl-D-aspartate receptor-mediated modulations of the anti-allodynic effects of 5-HT1B/1D receptor stimulation in a rat model of trigeminal neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Cycloserine; Dihydroergotamine; Disease Models, Animal; Drug Syne | 2011 |
Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Topics: Analgesics, Opioid; Animals; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Mor | 1999 |